SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-288377
Filing Date
2023-12-04
Accepted
2023-12-04 16:09:02
Documents
12
Period of Report
2023-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d852052d8ka.htm   iXBRL 8-K/A 25808
  Complete submission text file 0001193125-23-288377.txt   148951

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA advm-20231103.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20231103_lab.xml EX-101.LAB 17942
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20231103_pre.xml EX-101.PRE 11246
6 EXTRACTED XBRL INSTANCE DOCUMENT d852052d8ka_htm.xml XML 3743
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36579 | Film No.: 231463093
SIC: 2836 Biological Products, (No Diagnostic Substances)